C12ORF29 antibody (N-Term)
Quick Overview for C12ORF29 antibody (N-Term) (ABIN951538)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 68-96, N-Term
-
Specificity
- This antibody recognizes CL029 (N-term)
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human, Mouse.
-
Purification
- Peptide Affinity Chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 68-96 amino acids from the N-terminal region of Human CL029 Genename: C12orf29
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS, 0.09 % (W/V) Sodium Azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- C12ORF29 (Chromosome 12 Open Reading Frame 29 (C12ORF29))
-
Alternative Name
- C12orf29
-
Background
- Encoding over 1,100 genes within 132 million bases, chromosome 12 makes up about 4.5 % of the human genome. A number of skeletal deformities are linked to chromosome 12 including hypochondrogenesis, achondrogenesis and Kniest dysplasia. Noonan syndrome, which includes heart and facial developmental defects among the primary symptoms, is caused by a mutant form of PTPN11 gene product, SH-PTP2. Chromosome 12 is also home to a homeobox gene cluster which encodes crucial transcription factors for morphogenesis, and the natural killer complex gene cluster encoding C-type lectin proteins which mediate the NK cell response to MHC I interaction. Trisomy 12p leads to facial development defects, seizure disorders and a host of other symptoms varying in severity depending on the extent of mosaicism and is most severe in cases of complete trisomy. The C12orf29 gene product has been provisionally designated C12orf29 pending further characterization.
-
Molecular Weight
- 37490 Da
-
Gene ID
- 91298
-
NCBI Accession
- NP_001009894
Target
-